Topics

FDA green lights AstraZeneca's asthma drug Fasenra for self-administration

23:13 EDT 3 Oct 2019 | Reuters

British drugmaker AstraZeneca said on Friday that the U.S. Food and Drug Administration (FDA) has approved self-administration of its asthma treatment Fasenra which uses a pre-filled, single-use auto-injector pen.

Original Article: FDA green lights AstraZeneca's asthma drug Fasenra for self-administration

NEXT ARTICLE

More From BioPortfolio on "FDA green lights AstraZeneca's asthma drug Fasenra for self-administration"

Quick Search

Relevant Topics

AstraZeneca
AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and employing 62,000 people, around a sixth of which are dedic...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...